Generate Biomedicines, Inc. · NASDAQ:GENB
Generate Biomedicines, Inc. shareholders
As of Jun 30, 2026, 82 institutions reported holding Generate Biomedicines, Inc., 77.9% of its shares. Largest: Flagship Pioneering, LLC, Fidelity and Capital Group. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Generate Biomedicines, Inc. | Change | Filed |
|---|---|---|---|---|
| Flagship Pioneering, LLC | 62.7M | 48.8% | no change | Aug 14, 2026 |
| Fidelity | 5.22M | 4.1% | +1M | Aug 13, 2026 |
| Capital Group | 4.22M | 3.3% | +211K | Aug 12, 2026 |
| Braidwell LP | 3.28M | 2.6% | −309K | Aug 14, 2026 |
| T. Rowe Price | 2.16M | 1.7% | +46,994 | Aug 14, 2026 |
| Norges Bank | 2.09M | 1.6% | first report | Aug 12, 2026 |
| ARCH Venture Management, LLC | 1.94M | 1.5% | no change | Aug 14, 2026 |
| HarbourVest Partners LLC | 1.72M | 1.3% | no change | Aug 14, 2026 |
| BlackRock | 1.66M | 1.3% | new | Aug 7, 2026 |
| Vanguard | 1.49M | 1.2% | +1.34M | Aug 13, 2026 |